OOIR: Observatory of International Research

Papers

(The TQCC of BMJ Evidence-Based Medicine is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)

Article	Citations
High-value care education can learn from the evidence-based medicine movement: moving beyond competencies and curricula to culture	96
Proposed framework for unifying disease definitions in guideline development	86
Challenges to delivering evidence-based management for long COVID	79
Development of a generalised tool for evaluating success of clinical practice guidelines implementation (A-GIST)	69
Rapid reviews methods series: assessing the appropriateness of conducting a rapid review	67
FDA’s dilemma with the aducanumab approval: public pressure and hope, surrogate markers and efficacy, and possible next steps	50
Randomized trials on non-pharmaceutical interventions for COVID-19: a scoping review	42
How to best convey continuous outcomes in patient decision aids	38
Gender and geographical bias in the editorial decision-making process of biomedical journals: a case-control study	36
Decision architecture randomisation: extremely efficient clinical trials that preserve clinician and patient choice?	35
Associations between device-measured and self-reported physical activity and common mental disorders: Findings from a large-scale prospective cohort study	34
Global considerations for informed consent with shared decision-making in the digital age	33
Making sustainable healthcare decisions: three turns towards sustainable guidelines	32
Measuring progress in institutionalising evidence-informed priority-setting in the Indian healthcare system: an application using the iProSE scale	28
Deceptive shifts in cancer stage distribution	27
Deaths attributed to the use of medications purchased online	26
Leading with options or issues to support purposeful shared decision-making in clinical practice	23
Patient-reported outcomes and acupuncture-related adverse events are overlooked in acupuncture randomised controlled trials: a cross-sectional meta-epidemiological study	23
Acupuncture for acute migraine attacks in adults: a systematic review and meta-analysis	23
Exploring the diverse definitions of ‘evidence’: a scoping review	22
Assessing proposals to update established screening strategies	21
Ambiguity in care delivery terminology: implications that affect pragmatic clinical trials using non-pharmacological interventions	21
Genetic predisposition, modifiable lifestyles, and their joint effects on human lifespan: evidence from multiple cohort studies	21
iHealthFacts: a health fact-checking website for the public	20
Dynamic intervention strategies await inclusion in clinical evidence synthesis	20

Evidence-based medicine has already adapted and is very much alive	19
Exploring adaptive health technology assessment for evaluating 10 cancer interventions: insights and lessons from a pilot study in India	19
An opportunity for evidence-based care of individuals with monkeypox	18
How to use the regulatory data from Health Canada for secondary analyses on new drugs, biologics and vaccines	17
Is a one-size-fits-all ‘12-month rule’ appropriate when it comes to the last search date in systematic reviews?	16
Challenges in the selection and measurement of outcomes in psychiatric trials	16
Direct-to-consumer advertising: a modifiable driver of overdiagnosis and overtreatment	14
Catalogue of bias: novelty bias	14
Using a journal club to navigate a maze of COVID-19 papers in a front-line hospital service	14
Piloting a new method to estimate action thresholds in medicine through intuitive weighing	14
Survey of US physicians’ attitudes and knowledge of AI	12
Overcoming challenges in the implementation of clinical practice guidelines in China	12
Interventions for Menière’s disease: an umbrella systematic review	11
Ecological study estimating melanoma overdiagnosis in the USA using the lifetime risk method	11
Call for emergency action to limit global temperature increases, restore biodiversity and protect health	11
Improving peer review of systematic reviews and related review types by involving librarians and information specialists as methodological peer reviewers: a randomised controlled trial	11
Rapid reviews methods series: Guidance on assessing the certainty of evidence	11
De-escalation of dual antiplatelet therapy for patients with acute coronary syndrome after percutaneous coronary intervention: a systematic review and network meta-analysis	11
Development of the Reporting Infographics and Visual Abstracts of Comparative studies (RIVA-C) checklist and guide	11
How to interpret studies using Mendelian randomisation	10
Correspondence on “How methodological pitfalls have created widespread misunderstanding about long COVID” by Høeget al	10
Rapid Reviews Methods Series: Involving patient and public partners, healthcare providers and policymakers as knowledge users	10
Enhancing the transparency of clinical practice guidelines by prospective registration: the PREPARE platform	10
Perspectives of clinicians and screening candidates on shared decision-making in prostate cancer screening with the prostate-specific antigen (PSA) test: a qualitative study (PROSHADE study)	10
Clinical effect and contributing factors of acupuncture for knee osteoarthritis: a systematic review and pairwise and exploratory network meta-analysis	10
Time deficiency: an affliction of healthcare systems and how to ameliorate it	10
Adherence to the Guideline for Reporting Evidence-based practice Educational interventions and Teaching (GREET) of studies on evidence-based healthcare e-learning: a cross-sectional study	9
Assessing the magnitude of reporting bias in trials of homeopathy: a cross-sectional study and meta-analysis	9
Consistency between trials presented at conferences, their subsequent publications and press releases	9
Reducing the residue of retractions in evidence synthesis: ways to minimise inappropriate citation and use of retracted data	9
Likelihood ratio interpretation of the relative risk	9
Perspectives on the production, and use, of rapid evidence in decision making during the COVID-19 pandemic: a qualitative study	9
Clinical trial design and treatment effects: a meta-analysis of randomised controlled and single-arm trials supporting 437 FDA approvals of cancer drugs and indications	8
Strengthening transparency in randomised trials related to multimorbidity: key points and recommendations to guide reporting	8
Unknowns of drug company payment disclosure: why the UK needs payment transparency legislation	8
Reporting and methodological quality of studies that use Mendelian randomisation in UK Biobank: a meta-epidemiological study	8
AI in healthcare: an introduction for clinicians	8
Responsible dissemination of health and medical research: some guidance points	8
Using absolute risk reduction to guide the equitable distribution of COVID-19 vaccines	8
Retrieval barriers in individual participant data reviews with network meta-analysis	8
Component network meta-analysis in a nutshell	8
Problem-based shared decision-making in diabetes care: a secondary analysis of video-recorded encounters	8
Best way not to misuse p values is not to draw definitive conclusions about hypotheses	8
Perspectives from China, India and Sri Lanka on the drivers and potential solutions to overuse and overdiagnosis	7
Preventing overdiagnosis and overuse: proposed guidance for guideline panels	7
Revisiting the value of Archie Cochrane’s contributions	7
Clinician and health service interventions to reduce the greenhouse gas emissions generated by healthcare: a systematic review	7
Preventable deaths from SARS-CoV-2 in England and Wales: a systematic case series of coroners’ reports during the COVID-19 pandemic	7